SCHEMBL30708172

SCHEMBL30708172

CCN1CCN(c2ccc3cc(-c4cn5cc(C)nc(C)c5n4)c(=O)oc3c2)C[C@@H]1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.38
RAB9A P51151 5/20 0.38
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAPT P10636 3/20 0.35
POLB P06746 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
ALK Q9UM73 1/20 0.34
TP53 P04637 5/20 0.33
THRB P10828 1/20 0.33
LMNA P02545 1/20 0.33
PKM P14618 1/20 0.33
SLC16A3 O15427 1/20 0.32
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15069066 1.00 NPC1 (0.38) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL15068776 1.00 NPC1 (0.38) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL15068551 1.00 NPC1 (0.38) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL15069027 0.91 NPC1 (0.37) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL15068856 0.91 NPC1 (0.37) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL27262304 0.91 NPC1 (0.37) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL21301319 0.91 NPC1 (0.37) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL21324749 0.91 NPC1 (0.37) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL21301234 0.91 NPC1 (0.37) NPC1RAB9AALDH1A1KDM4EL3MBTL1
SCHEMBL15068502 0.91 NPC1 (0.38) NPC1RAB9AALDH1A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024006287-A2 ANTIVIRAL COMPOUNDS USEFUL AGAINST SARS-COV-2 UNIVERSITY OF KANSAS (US) 2024-01-04 WO claimed
WO-2024006287-A2 ANTIVIRAL COMPOUNDS USEFUL AGAINST SARS-COV-2 UNIVERSITY OF KANSAS (US) 2024-01-04 WO disclosed